Beijing, Sep 30 (Prensa Latina) China today reaffirmed its commitment to set a fair and reasonable price when it brings its Covid-19 vaccines to market, and even plans to donate some to low-income countries.
Wang Wenbin, spokesman for the Ministry of Foreign Affairs, denied reports that the cost of these medicines is higher than those of similar medicines obtained in Europe and the United States.
He reiterated the plans to contribute to the worldwide availability of these substances, once the effectiveness and safety to protect from the respiratory condition and the SARS-CoV-2 coronavirus, which causes it, have been proven.
Wang also assured that Beijing will give priority to developing nations through various channels, including grants and non-reimbursable assistance.
China has 11 vaccines in various stages of clinical trials, four are nearing completion of final research and have already been applied to thousands of foreign service officers, military personnel in UN peacekeeping missions, and health and aviation employees as part of an emergency program.
Weeks ago, the local press reported that two of the inactive type will go on sale next December at less than 1,000 yuan ($144.00) for two doses, while the recombinant Ad5-nCoV is the only one so far with a patent and could also be marketed soon at about 100 yuan ($14.64) per injection.
The Asian giant has been without indigenous cases of Covid-19 for 45 days, accumulating 4,746 deaths and 91,49 confirmed patients of the disease.
(Taken from PL)